Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma.

Hervey-Jumper SL, Garton HJ, Lau D, Altshuler D, Quint DJ, Robertson PL, Muraszko KM, Maher CO.

J Neurosurg Pediatr. 2014 Aug;14(2):121-8. doi: 10.3171/2014.4.PEDS13244. Epub 2014 Jun 6.

PMID:
24905841
2.

Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study.

Ozer E, Sarialioglu F, Cetingoz R, Yüceer N, Cakmakci H, Ozkal S, Olgun N, Uysal K, Corapcioglu F, Canda S.

Pathol Res Pract. 2004;200(7-8):501-9.

PMID:
15462497
3.

Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.

Tural S, Gercek A, Konya D, Ozgen S, Toplamoglu H, Ozek MM.

J Clin Neurosci. 2009 Sep;16(9):1199-202. doi: 10.1016/j.jocn.2008.10.026. Epub 2009 Jun 12.

PMID:
19524442
4.

Functional VEGF and VEGF receptors are expressed in human medulloblastomas.

Slongo ML, Molena B, Brunati AM, Frasson M, Gardiman M, Carli M, Perilongo G, Rosolen A, Onisto M.

Neuro Oncol. 2007 Oct;9(4):384-92. Epub 2007 Aug 17.

6.

The prognostic significance of glial fibrillary acidic protein staining in medulloblastoma.

Goldberg-Stern H, Gadoth N, Stern S, Cohen IJ, Zaizov R, Sandbank U.

Cancer. 1991 Aug 1;68(3):568-73.

7.

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.

Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.

PMID:
12553021
8.

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN.

Mod Pathol. 2005 Jan;18(1):143-52.

9.

Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.

Han H, Silverman JF, Santucci TS, Macherey RS, d'Amato TA, Tung MY, Weyant RJ, Landreneau RJ.

Ann Surg Oncol. 2001 Jan-Feb;8(1):72-9.

PMID:
11206229
10.

The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.

Mentzel T, Brown LF, Dvorak HF, Kuhnen C, Stiller KJ, Katenkamp D, Fletcher CD.

Virchows Arch. 2001 Jan;438(1):13-22.

PMID:
11213831
11.

[Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].

Kaszper E, Hanzély Z, Szende B, Dabasi G, Garami M, Schuler D, Hauser P.

Magy Onkol. 2008 Dec;52(4):351-5. doi: 10.1556/MOnkol.52.2008.4.3. Hungarian.

PMID:
19068462
12.

The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.

Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI; Tumour and Angiogenesis Research Group..

Cancer. 2001 Nov 15;92(10):2569-77.

PMID:
11745191
13.

Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.

Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W.

Clin Cancer Res. 2007 Jan 1;13(1):76-80.

14.

Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.

Jia JB, Zhuang PY, Sun HC, Zhang JB, Zhang W, Zhu XD, Xiong YQ, Xu HX, Tang ZY.

J Cancer Res Clin Oncol. 2009 Jun;135(6):847-54. doi: 10.1007/s00432-008-0521-0. Epub 2008 Dec 10.

PMID:
19066962
15.
16.
17.

Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.

Fukuda S, Shirahama T, Imazono Y, Tsushima T, Ohmori H, Kayajima T, Take S, Nishiyama K, Yonezawa S, Akiba S, Akiyama S, Ohi Y.

Cancer. 1999 Mar 15;85(6):1323-30.

PMID:
10189138
18.

Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.

Łastowska M, Jurkiewicz E, Trubicka J, Daszkiewicz P, Drogosiewicz M, Malczyk K, Grajkowska W, Matyja E, Cukrowska B, Pronicki M, Perek-Polnik M, Perek D, Dembowska-Bagińska B.

J Neurooncol. 2015 May;123(1):65-73. doi: 10.1007/s11060-015-1779-0. Epub 2015 Apr 11.

19.

Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.

Capp C, Wajner SM, Siqueira DR, Brasil BA, Meurer L, Maia AL.

Thyroid. 2010 Aug;20(8):863-71. doi: 10.1089/thy.2009.0417.

PMID:
20615131
20.

Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression.

Vlaykova T, Laurila P, Muhonen T, Hahka-Kemppinen M, Jekunen A, Alitalo K, Pyrhönen S.

Melanoma Res. 1999 Feb;9(1):59-68.

PMID:
10338335

Supplemental Content

Support Center